Eucreas是由诺华制药公司研制的Galvus (维格列汀) 和二甲双胍的复方制剂。 Eucreas将用于二甲双胍最大耐受剂量仍不能有效控制血糖的患者或目前已联合使用Galvus与二甲双胍的患者。
基于64个网页-相关网页
GALVUS (维格列汀片), 是由投诉人研制的一种全新的,一天一次用于2型糖 尿病的口服药物.
基于43个网页-相关网页
But another molecule created when the body metabolizes Galvus does build up in the kidney.
FORBES: Magazine Article
The FDA could render a verdict on Merck's Januvia by mid-October and Novartis' Galvus by December.
FORBES: Health
Novartis created its first DPP4 drug candidate in 1996 and by 1998 had invented Galvus.
FORBES: Merck Starts Diabetes Race
应用推荐
模块上移
模块下移
不移动